Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States

: | Frankfurt Stock Exchange: NB3 | Nasdaq: NBIX

Similar to: AstraZeneca Plc, Transgene SA, Skystar Bio-Pharmaceutical Co.

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

News & Analysis

You may also be interested in: